Corbus Pharmaceuticals Holdings, Inc.
CRBP
Revenue
0.00
0.000.00%
6 Months ChangeAssets
151.98M
▲26.23M▲20.86%
3 Months ChangeLiabilities
26.44M
▼-2.34M▼-8.14%
3 Months ChangeFree Cash Flow
-15.11M
▼-4.49M▼-42.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-03
Form 8-K
ID: 0000950170-24-102878
2024-08-20
Form 8-K
ID: 0000950170-24-098861
2024-08-06
Form 8-K
ID: 0000950170-24-091931
2024-08-06
Form 10-Q
ID: 0000950170-24-091922
2024-08-06
Form 8-K
ID: 0000950170-24-091219
2024-06-17
Form 8-K
ID: 0000950170-24-074032
2024-06-03
Form 8-K
ID: 0000950170-24-067651
2024-05-20
Form 8-K
ID: 0000950170-24-062436
2024-05-09
Form 8-K
ID: 0000950170-24-056291
2024-05-07
Form 10-Q
ID: 0000950170-24-054625